These findings provide insight into not only pathophysiological functions of Nrg1/ErbB4 signaling in epilepsy but also indicate that such signaling mechanism can be therapeutically manipulated to treat refractory epilepsy. This evidence concerns the gene NRG1 and epilepsy.